ࡱ> $( / 0DArialGothic BTtt- 0DGaramondhic BTtt- 0 DTimes New Romantt- 00DWingdingsRomantt- 0@DTahomagsRomantt- 0"PDMS MinchoRomantt- 01`DHandelGothic BTtt- 0R A .  @n?" dd@  @@`` D+       13VWXYZ[   mn       1     0AA@8ʚ;ʚ;g4CdCdy 0ppp@ <4dddd@w 0t, ___PPT10DMS Mincho}0=ott 01DTahomaho}0=ott 0" (___PPT9ph(c? -O  =7 UNIVERSITY COLLEGE OF PHARMACY Event: One day National Pharmacy Conference Awareness: NEPT: New Era in Pharmaceutical Trading Topic: Impact of WTO Pharmaceutical Trading - Some Thoughts Presentation by: PROF. DR. KHAWAJA AMJAD SAEED Principal, Hailey College of Banking & Finance University of the Punjab, Lahore. Email: kamjadsaeed@yahoo.com Date & Time: April 12, 2007, 10: 00a.m.r PyP ggc$cg g+cg:cgcccycggcX,ZWELCOME TO OUR PROGRAM cP Y8IMPACT OF WTO ON PHARMACEUTICAL TRADING: SOME THOUGHTS 99c";Prof. Dr. Khawaja Amjad Saeed* Email: kamjadsaeed@yahoo.com <Z<cP  cSources  c$Roundtable of Prime Minister on Business Plus-March 2007. KSE Quotation Sheet Downloads from Websites: - India - Thailand - Australia - Other Countries >hn;nnaJ1: WTO$n- The only global international organization dealing with rules of trade between nations - Goals: - Help producers of goods and services, exporters and importers conduct their business - Welfare of people of member countries - 1995 came into being - 2000 New talks started on agriculture and services:8aawa 1: WTO $$ KN2: PHARMACEUTICALS PAKISTAN S POSITION ((c$ +%N2: PHARMACEUTICALS PAKISTAN S POSITION ((c$ ,&N2: PHARMACEUTICALS PAKISTAN S POSITION ((c$ -'N2: PHARMACEUTICALS PAKISTAN S POSITION ((c$ LN2: PHARMACEUTICALS PAKISTAN S POSITION ((c$ b/N2: PHARMACEUTICALS PAKISTAN S POSITION ((c$ MN2: PHARMACEUTICALS PAKISTAN S POSITION ((c$ NN2: PHARMACEUTICALS PAKISTAN S POSITION ((c$ ON2: PHARMACEUTICALS PAKISTAN S POSITION ((c$ [N2: PHARMACEUTICALS PAKISTAN S POSITION ((c$ PN2: PHARMACEUTICALS PAKISTAN S POSITION ((c$ \3: TRIPS c$ ]3: TRIPS c$ Q3: TRIPS c$ ^3: TRIPS c$ _3: TRIPS c$ `3: TRIPS c$ a3: TRIPS c$ b3: TRIPS c$ /46X$Y%Z&f0KLMNOPQR  0` 3` ff>>\fg` J*T333` QYmx~3ft` \ғhEy`` cb^DDf`Y˵W` sg7xGr` K%ޯd{mG/` 33f>?" dd@,?nFd@    @ `  n?" dd@   @@``PR    @ ` `<p>> ,(  , , 6 #" `b `  X*  , 6 #" `` `  Z* xT ~ , "~\ { , "{ , c BB CDEFd @ bb   H   T W6Vw}\gFQ6<1++11 1L b6xQrq 6\}N   - c    0 A Q g     S    6N KawF bFy0 a*ly7lE;uz  B | a F 0 ! 1 < B < & l L 0  @`"T  , c |BC+DEFyd @ ==gL6cI}\eA& w6m!W<! &<W!r6W}F6\}>68QNlX^XH8+Sgg|@`"Jo 5 J ,  B! CDEF @ ))\*l{FDNF W% W ! !   ! 6X L b x_ /aF6b}SA$|l\\TX@`s"*  T  u4  , B C%DEF ss&QW}k6D Q r 8 N c t y y ;t Qi gS }8     T   :0\-Q4*%%v*o(V}5q;  S   < s } l \ g} \, L ;n &  Z}\[6 }WF<! e C }h m W ]  ,t B RxkqA,Rg@`" {b  ,  BCDEFy @ ,,Lh6\}mWG &a*zCxsh-&jG]~5g6&LLZ\@`s"*   u(   ,  BCDE|Fy @ __@% M|f4@{ f0`lA}L\A+h MB6ww FJl{ 0V|{J  *5KlGn a*:Pf\|6 /6Kbf|F kP}5x}VvaP@@@`s"*   =>   , c BlCrDEF"d@ rlrl@`"~  , 6г " `}  T Click to edit Master title style! ! , 6h #" ``   Z* $ , 0T " `  RClick to edit Master text styles Second level Third level Fourth level Fifth level!     SB , s *޽h ? 3___PPT10i. u%.+D=' | = @B +  Stream  0 0](  0xT ~ 0 "~\ { 0 "{ 0 c BB CDEFd @ bb   H   T W6Vw}\gFQ6<1++11 1L b6xQrq 6\}N   - c    0 A Q g     S    6N KawF bFy0 a*ly7lE;uz  B | a F 0 ! 1 < B < & l L 0  @`"T  0 c |BC+DEFyd @ ==gL6cI}\eA& w6m!W<! &<W!r6W}F6\}>68QNlX^XH8+Sgg|@`"Jo 5 J 0  B! CDEF @ ))\*l{FDNF W% W ! !   ! 6X L b x_ /aF6b}SA$|l\\TX@`s"*  T  u4 0 B C%DEF ss&QW}k6D Q r 8 N c t y y ;t Qi gS }8     T   :0\-Q4*%%v*o(V}5q;  S   < s } l \ g} \, L ;n &  Z}\[6 }WF<! e C }h m W ]  ,t B RxkqA,Rg@`" {b 0  BCDEFy @ ,,Lh6\}mWG &a*zCxsh-&jG]~5g6&LLZ\@`s"*   u(   0  BCDE|Fy @ __@% M|f4@{ f0`lA}L\A+h MB6ww FJl{ 0V|{J  *5KlGn a*:Pf\|6 /6Kbf|F kP}5x}VvaP@@@`s"*   =>   0 c BlCrDEF"d@ rlrl@`"~  0 < "F  $ T Click to edit Master title style! !  0 04 " `   $ W#Click to edit Master subtitle style$ $  0 6$ #" `` `  X*  0 6$ #" `b  $ Z*  0 6$ #" `d ` $ Z* B 0 s *޽h ? 3___PPT10i. u%.+D=' | = @B + 0 zr< (  < < 0 P    P*   < 0     R*  d < c $ ?   < 0  0  RClick to edit Master text styles Second level Third level Fourth level Fifth level!     S < 60 _P   P*   < 6L _   R*  H < 0޽h ? 3380___PPT10.TpY P (    0̛|  P   |  X*   0ȟ|     |  Z*   6|  _P  |  X*   6|  _  |  Z* H  0޽h ? 3380___PPT10.pt  0 PT(  Tr T S ,  H T 0޽h ? 3___PPT10i.,,+D=' | = @B +q  0 ` (  r  S $ ,a `   $ f  0"`tP` H  0޽h ? 3___PPT10i.{ +D=' | = @B +e  0 |tP   (    Hd$  , G  $   <$ ,  $    0$   p * Founder Principal, Hailey College of Banking & Finance, University of the Punjab, Lahore Pakistan (2003----), Member Governing Council, International Federation of Accountants (IFAC), New York (1997-2000), President, South Asian Federation of Accountants (SAFA) (1997), President, Institute of Cost and Management Accountants of Pakistan (1997-2000), President, Association of Management Development Institutions of South Asia (AMDISA) (1993-96), Pro Vice-Chancellor University of the Punjab, Lahore (1994-1996), Founder Director, Institute of Business Administration (IBA), University of the Punjab, Lahore (1973-1996).qqc   < $ 0 D<4___PPT9  PRESENTATION WTO Pharmaceuticals- Pakistan Position s TRIPS"B" BcH  0޽h ? 3___PPT10i.{0L+D=' | = @B +  0  @|(  @ @ B7$  , `@  $  @ <b$ , ` $ "p`PpH @ 0޽h ? 3___PPT10i.3|_k+D=' | = @B +} K 0 ` $(  r  S dz$ , `  $ r  S <{$, ` $ H  0޽h ? 3___PPT10i.+D=' | = @B +  0 p\-(  \r \ S W$ ,`  $ { \ 0$ @ ` - 149 members - Constituents - Committees - Working Groups - Council for Trade in goods (various committees) - Council for Trade in Services - Council for TRIPS: Trade-Related Aspects of Intellectual Property Rights aH \ 0޽h ? 3___PPT10i.Ι+D=' | = @B + L 0   (    B0$  ,0  $   0h$  ` )1. Pharmaceutical Manufacturing Units in Pakistan - Units Number % - Local 286* 90 - Multinational 030** 10 316 100 3Sa&aa ac a>c LB  c $D   LB  c $Dc  c LB   c $D `  LB   c $Dc ` c H  0޽h ? 3___PPT10i. K+D=' $= @B + $ 0 ` X}(  X X B~  ,`     X 0<{ 0 `P  1. Pharmaceutical Manufacturing Units in Pakistan - Local Concentration Number - Punjab 165 - Sindh 076 - NWFP 037 - Balochistan 05 - Azad Kashmir 03 286*x3a&aa ac vc >g   LB  X c $DLB  X c $DH X 0޽h ? 3___PPT10i.IY+D=' = @B + % 0 `4(  ` ` B|$  ,  $  ` 0ȵ$  ` V1. Pharmaceutical Manufacturing Units in Pakistan - Multinational Concentration - Sindh 23 - Punjab 05 - Balochistan 02 30**x4[a&aa ac >c ,V LB ` c $D  LB ` c $D^^H ` 0޽h ? 3___PPT10i.@+D=' = @B + & 0 6.h(  h h B`$  ,  $  h 0$  ` <2. Pharmaceutical Industry in Pakistan 1. WHO study : World medicine situation. - Pakistan spending 77% of their health care budgets on buying medicines - Government spending 0.5  0.8% of GNP on health - Competing against India & China: two low cost drug manufacturers8a%aaH h 0޽h ? 3___PPT10i.2+D=' = @B + M 0   6(     B$  ,  $ `   0$  `  2. Pharmaceutical Industry in Pakistan 2. Challenges: - Establish and upgrade its drug manufacturing units - Strengthen infrastructure - Increase export capability:a%aaH  0޽h ? 3___PPT10i.˟+D=' = @B + 0 0 (    Bhs   ,  s  D  0s   `  3. Pakistan: Pharmaceutical Industry: Decline in Profitability 1. Cost Increase - 90% over the last five years - Factors: - Cumulative inflation of 76% - Devaluation of Pakistani currency by 85% in relation to US$T! ka#aaaaaa!aa c kaH  0޽h ? 3___PPT10i.V+D=' $= @B +F N 0 ]U  (     Bs   ,  s     0s   `  3. Pakistan: Pharmaceutical Industry: Decline in Profitability 2. Insufficient Price Increases - Do not compensate for cost increases - Price increase in the last five years - Controlled Drugs: 71% increase - Decontrolled Drugs:29% increaseva#aaaa a.avc H  0޽h ? 3___PPT10i.ବ+D=' s = @B + O 0    (     B+s   ,o  s     0@s   `\TL___PPT9.& 4. Listed Pharmaceuticals on KSE: April 09, 2007 1. List Companies Abbott Lab Ferozesons Lab Galaxo Smith Kline Highnoon Lab Otsuka Pak Ltd. Sanafi Aventis Pak Ltd. Wyeth Pak Ltd. Searle Pak2~na/aaaa~aP    p`PpH  0޽h ? 3___PPT10i.gK+D=' s = @B + P 0  <(    BKs   ,o  s  f  0Ys   ` 4. Listed Pharmaceuticals on KSE: April 09, 2007 2. Listed Market Capitalization Share 1.48% 3. Turnover 0.028 4. Traded Value 0.015 % 5. 30  Index (KSE) No pharmaceutical company F2a/aap`PpH  0޽h ? 3___PPT10i.j1+D=' s = @B +@  0 WOp (    B`Qs   ,o  s    0.s   `p\TL___PPT9.& M5. In Search of Health Policy 2010 for Pakistan - Being prepared - Features Improve effective access to healthcare Reduction in widespread prevalence of communicable diseasesj1dna.aadc p`PpH  0޽h ? 3___PPT10i.{@n+D=' s = @B +k Q 0 z  (     Bvs   ,o  s  <   0xs  $ ` PH@___PPT9" 5. In Search of Health Policy 2010 for Pakistan Removal of Management / Professional deficiencies in health system Promoting greater & gender equity Bridging basic nutrition gap in the target population Good governance at both directorate and agency levelsN1na.ac p`PpH  0޽h ? 3___PPT10i.@[O0+D=' s = @B +  0 *"  (      Bts   ,o  s     0$ ] `i 1. TRIPS-Requirements Main requirements that nations laws must meet for: 1. Copyrights, including 2. The rights of - Performers - Producers of sound recordings and broadcasting organizationsGaaa4aaaaaaGc p`PpH   0޽h ? 3___PPT10i.{`g+D=' s = @B +  0 ,$ $(  $ $ Bps   ,$b  s   $ 0s   ` 1. TRIPS-Requirements Main requirements that nations laws must meet for: 3. Geographical indications including - Appellations of origin - Industrial Design - Integrated circuit layout designs - Patents - Monopolies for the developers of new plant varieties - Trade marks - Trade Dresses - Undisclosed or confidential information |maa5ac#cccp`PpH $ 0޽h ? 3___PPT10i.|s+D=' s = @B +] R 0 tl@ 0(   / Bs   ,$b  s  . 0 0s   ` 1. TRIPS-Requirements Main requirements that nations laws must meet for: 4. Specifies - Enforcement procedures - Remedies - Dispute - TRIPS introduced intellectual property law into the international trading system for the first time. - Remains the most comprehensive international agreement on intellectual property to-date. yaa5ac cccaacp`PpH  0޽h ? 3___PPT10i.@+D=' s = @B +  0  ([(  ( ( Bs   ,  s   ( 0 b ~ ` %2. TRIPS & Pharmaceuticals 1. Effective January 1995. 2. Strong patent protection for pharmaceutical products & processes for 20 years 3. Impact: - Prices - Access to medicines:aaap`PpH ( 0޽h ? 3___PPT10i.|+D=' s = @B +m  0 | ,(  , , B |   ,  |  > , 0 |  p `  T2. TRIPS & Pharmaceuticals 4. Doha Ministerial Conference: DG-WHO  Indeed this is the first time in the 50 year history of the multilateral trading system that a separate ministerial declaration is being considered on intellectual property and public health issues. The Doha MinisterialX+aaaaap`PpH , 0޽h ? 3___PPT10i.| b+D=' s = @B +  0 .& 0(  0 0 BD|   ,0n  |   0 0$|   `0 2. TRIPS & Pharmaceuticals 4. Doha Ministerial Conference: DG-WHO Conference is providing a historic opportunity for WTO members to ensure that the TRIPS Agreement does not stand in the way of access to life saving medicines, especially in the poorest countries . 5 Measures recommended - Compulsory Licensing - Parallel Imports )0aaaaac aa,c p`PpH 0 0޽h ? 3___PPT10i.|[+D=' | = @B +a  0 xp 4(  4 4 BX|   ,0n  |  2 4 0-|   `PH@___PPT9" z3. TRIPS-Stakeholders Analysis Purchasers Prescribers & Dispensers Producers Products Price controls Patent-to-Third Party Parallel Imports Power of the Customer Patentable New Drugs Personnel Prevention Policies N naac, p`PpH 4 0޽h ? 3___PPT10i.|gR+D=' | = @B +  0 )! 8(  8 8 BxA|   , ^  |  ! 8 0M|   ` I4. Action Plan Based on Research, and presentations, please develop it. F;a a;ap`Pp 8 6lE|  {P  TThank you for joining us  6H 8 0޽h ? 3___PPT10i.|+L+D=' | = @B +  0 (  X  C <     S < 0    H  0޽h ? 3380___PPT10.߻0M   0 0(  X  C <   |   S Z| < 0  |   H  0޽h ? 3380___PPT10.߻zO% 0 p\((  \^ \ S <   |  \ c $| < 0  |   H \ 0޽h ? 3380___PPT10.߻Y& 0 d((  d^ d S <   |  d c $j< 0  |   H d 0޽h ? 3380___PPT10.߻Y' 0 l((  l^ l S <   |  l c $c| < 0  |   H l 0޽h ? 3380___PPT10.߻V/ 0 ((  ^  S <   |   c $\i| < 0  |   H  0޽h ? 3380___PPT10.߻og J 0 p (  X  C <   |   S $o| < 0  |   H  0޽h ? 3380___PPT10.@O K 0  (  X  C <   |   S 8t| < 0  |   H  0޽h ? 3380___PPT10.; L 0  (  X  C <   |   S z| < 0  |   H  0޽h ? 3380___PPT10.pf0d M 0  (  X  C <   |   S t| < 0  |   H  0޽h ? 3380___PPT10. N 0  (  X  C <   |   S <| < 0  |   H  0޽h ? 3380___PPT10.pp O 0  (  X  C <   |   S | < 0  |   H  0޽h ? 3380___PPT10.`7  P 0 0 (  X  C <   |   S | < 0  |   H  0޽h ? 3380___PPT10. Q 0 P (  X  C <   |   S | < 0  |   H  0޽h ? 3380___PPT10.Wlr $Do`jL|+0ȉ]46X0%bfEqfyeyڭ}omMh:v1Oh+'0T hp  FOSTERING TEAMWORK AtieqStreamhcbf389Microsoft Office PowerPoint@Ԃϭ@&L@tۖgWGSg  )'    """)))UUUMMMBBB999|PP3f333f3333f3ffffff3f̙3ff333f333333333f33333333f33f3ff3f3f3f3333f33̙33333f333333f3333f3ffffff3f33ff3f3f3f3fff3ffffffffff3ffff̙fff3fffff3fff333f3f3ff3ff33f̙̙3̙ff̙̙̙3f̙3f333f3333f3ffffff3f̙3f3f3f333f3333f3ffffff3f̙3f3ffffffffff!___www 4'A x(xKʦ """)))UUUMMMBBB999|PP3f3333f333ff3fffff3f3f̙f3333f3333333333f3333333f3f33ff3f3f3f3333f3333333f3̙33333f333ff3ffffff3f33f3ff3f3f3ffff3fffffffff3fffffff3f̙ffff3ff333f3ff33fff33f3ff̙3f3f3333f333ff3fffff̙̙3̙f̙̙̙3f̙3f3f3333f333ff3fffff3f3f̙3ffffffffff!___www___e_e____eee_e_e_e_eee_e_e__e_e_e_e_eeee_ee__e_e_e88888888888888888888888888888888888eeeee88888888888888888888888_e_e_ee___e_88888888888888888888eeeeee8888888888888888888eee_ee_e_e_e_888888888eeeeee_e_eee___eeee_ee_eeee_e_eeeeee__eee_ee__eee_e_e_eeeeee_e_eee_ee_e_e__eee__e88888888888888888888888888888888888888888888e8888888888888888888888888888888888888888888888888888888888_88888888888888888888888888888888888888e_________e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_8888888888888888ee888888888888eeeeeeeeeeeeeeeee8888888_e__e_8888888888_e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e_8888_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_ee_e_e_e_e_e_e_e_e_eeeeeeeeeee_e_e_e_e__e_e_e_e_e____e_e_e_e_e_e_e_e_e_e_eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee___e___e___e___e___e___e___e___e___e___e___e___e___e___e___e___e___e___e___e___eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee_e_e_e8888888888888888888888888888888_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_eeeeeee888e888888888888888888eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee_e__e__e__e8888888888888888888888e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e_eeeeeee88888e8888e88888e8888e888eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee_e_e_e_e_e_e_e_8_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee_e_e_e_e_e_e_e_e_e_e___ee_e_ee_____e__ee__e___ee__ee__e_ee_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_ee_eee_eee_eee_eee_eeee_eeeeee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_ee_e_e_e_e_e_e_e_e_e_e_e_e__e_e_ee__e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_eeee_eee_eee_eee_eee_ee_ee_eee_ee_ee_ee_eeeeeee_e_eee_ee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}Root EntrydO)Current UserSummaryInformation(~TPowerPoint Document(DocumentSummaryInformation8